CCRI’s first international research team is led by Prof George Vassiliou from the Stem Cell Institute, Cambridge, UK. It will deliver research in the Haematological Malignancies focus area under the Translational Cancer Research direction. The team started working in March 2021 and will receive €1,200,000 in funding from CCRI to carry out its work. The aim of establishing the ITL Haematology Group is to facilitate knowledge transfer and bridge collaboration between CCRI and the Cambridge Stem Cell Institute. The group consists of the deputy group leader, a postdoctoral researcher and two research assistants
Postdoctoral Scientist
Research Direction
Postdoctoral Scientist
Research Assistant
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
We are dedicated to creating a comprehensive map of DNA double-strand breaks, employing state-of-the-art genomic technologies and innovative bioinformatics approaches. By understanding the when, where, and how DSBs occur and are repaired, we aim to gain significant insights into their contribution to cancer biology.
A cornerstone of our research is to identify and understand the vulnerabilities introduced by DSBs in cancer cells. These vulnerabilities represent potential therapeutic targets that could be exploited to selectively kill cancer cells without harming normal cells.
Leveraging the vulnerabilities identified, our goal is to develop innovative therapeutic strategies that target the unique dependencies of cancer cells on certain DNA repair pathways. This includes the design of novel drugs and gene therapies that can enhance the efficacy of existing treatments and overcome resistance mechanisms.
We are always looking for talented and motivated reseachers and invetrsigators to join our team. If you are passionate about making a difference in the world of cancer research, explore our current openings for postdoctoral researchers, graduate students, and research technicians. Learn more about how you can contribute to our mission.
For more information, collaboration inquiries, or to discuss potential research opportunities, please contact us at:
Professor George Vassiliou, @ Cyprus Cancer Research Institute (CCRI)
